Clinical Trial Update: Pharmacokinetics of BIBR 277 in Hypertensive Patients [Phase 2]

View source ↗

Summary

Phase 2 pharmacokinetic study of BIBR 277 in hypertensive patients, detailing the drug's PK characteristics in this population.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• BIBR 277

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hypertension | Phase 2 | Status: COMPLETED